217 related articles for article (PubMed ID: 31804289)
21. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
Salpeter SR; Ormiston TM; Salpeter EE; Poole PJ; Cates CJ
Respir Med; 2003 Oct; 97(10):1094-101. PubMed ID: 14561016
[TBL] [Abstract][Full Text] [Related]
22. Use of beta-blockers in patients with COPD.
Andrus MR; Holloway KP; Clark DB
Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
[TBL] [Abstract][Full Text] [Related]
23. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
Le Jemtel TH; Padeletti M; Jelic S
J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
[TBL] [Abstract][Full Text] [Related]
25. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
Du Q; Sun Y; Ding N; Lu L; Chen Y
PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000
[TBL] [Abstract][Full Text] [Related]
26. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
Mersfelder TL; Shiltz DL
Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
[No Abstract] [Full Text] [Related]
27. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
[TBL] [Abstract][Full Text] [Related]
28. Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality.
Mascarenhas J; Azevedo A; Bettencourt P
Curr Opin Pulm Med; 2010 Mar; 16(2):106-11. PubMed ID: 20042977
[TBL] [Abstract][Full Text] [Related]
29. Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.
Wade C; Wells JM
Expert Rev Respir Med; 2020 Jul; 14(7):671-678. PubMed ID: 32250198
[TBL] [Abstract][Full Text] [Related]
30. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis.
van Gestel YR; Hoeks SE; Sin DD; Welten GM; Schouten O; Witteveen HJ; Simsek C; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
Am J Respir Crit Care Med; 2008 Oct; 178(7):695-700. PubMed ID: 18565952
[TBL] [Abstract][Full Text] [Related]
31. Acute heart failure with accompanying chronic obstructive pulmonary disease: should we focus on beta blockers?
Ege MR; Guray U; Guray Y; Yilmaz MB; Yucel O; Zorlu A; Tandogan I
Herz; 2012 Nov; 37(7):796-800. PubMed ID: 22699995
[TBL] [Abstract][Full Text] [Related]
32. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly.
Leitao Filho FS; Choi L; Sin DD
Curr Opin Pulm Med; 2021 Mar; 27(2):125-131. PubMed ID: 33332878
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
[TBL] [Abstract][Full Text] [Related]
34. Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.
Dong YH; Chang CH; Wu LC; Lai MS
Eur J Clin Pharmacol; 2016 Oct; 72(10):1265-1273. PubMed ID: 27444174
[TBL] [Abstract][Full Text] [Related]
35. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
[TBL] [Abstract][Full Text] [Related]
36. Multicentric study on the beta-blocker use and relation with exacerbations in COPD.
Puente-Maestu L; Calle M; Ortega-González A; Fuster A; González C; Márquez-Martín E; Marcos-Rodriguez PJ; Calero C; Rodríguez-Hermosa JL; Malo de Molina R; Aburto M; Sobradillo P; Alcázar B; Tirado-Conde G;
Respir Med; 2014 May; 108(5):737-44. PubMed ID: 24635914
[TBL] [Abstract][Full Text] [Related]
37. Beta-blocker use in heart failure patients with airways disease.
Shaw SM; Hasleton J; Williams SG
Clin Cardiol; 2009 Jul; 32(7):393-6. PubMed ID: 19609894
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
Richardson A; Tolley E; Hartmann J; Reedus J; Bowlin B; Finch C; Sands CW; Self T
Respir Med; 2016 Oct; 119():135-140. PubMed ID: 27692135
[TBL] [Abstract][Full Text] [Related]
39. Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.
Chung CM; Lin MS; Chang ST; Wang PC; Yang TY; Lin YS
Mayo Clin Proc; 2022 Mar; 97(3):531-546. PubMed ID: 35135688
[TBL] [Abstract][Full Text] [Related]
40. Update in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failure.
Zeng Q; Jiang S
J Thorac Dis; 2012 Jun; 4(3):310-5. PubMed ID: 22754671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]